• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL DELTEC PORT-A-CATH II PORTS; PORT AND CATHETER, IMPLANTED,SUBCUTANEOUS,INTRAVAS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL DELTEC PORT-A-CATH II PORTS; PORT AND CATHETER, IMPLANTED,SUBCUTANEOUS,INTRAVAS Back to Search Results
Model Number 21-4083-24
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Codes Pain (1994); Swelling/ Edema (4577)
Date of Event 11/09/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Event or Problem Description
It was reported that after the patient was implanted in the infusion port, he found that the right breast and side of the chest were swollen with slight pain, and physical examination: the outer quadrant of the right breast and the tissue near the port seat of the side chest near the port of infusion were edematous, the skin was not red and swollen, and it was mildly tender.Contrast examination shows that there is a small amount of contrast agent in the catheter part, and after local treatment, local pain, swelling and other symptoms are relieved.Expert identification: 1 drug extravasation 2 catheter leakage.
 
Additional Manufacturer Narrative
Other, other text: h6: event problem and evaluation codes: updated.H3: device evaluated by manufacturer: updated.H10: device evaluation: one (1) photo was attached to the complaint created.The photo was used to conduct the device analysis since the physical unit had not been received.The photo, an x-ray image, showed an implanted port-a-cath port and a catheter.In the image part of the catheter, a splat in the catheter was observed.Thus, the reported failure mode, leaking catheter, was confirmed from the photo provided.However, no product had been received to conduct a functional test.After reviewing the mitigations that were performed during the manufacturing process, and analyzing the photo provided, the root cause of the failure mode could not ne be determined.No corrective actions were required because the mitigations in place were revised and executed in accordance with procedure.This failure will continue to be monitored to determine if new actions need to be taken.A device history record (dhr) review was conducted which indicated all inspections were completed and no issues were noted during manufacture.This remediation mdr was generated under protocol (b)(4), as a result of warning letter (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTEC PORT-A-CATH II PORTS
Common Device Name
PORT AND CATHETER, IMPLANTED,SUBCUTANEOUS,INTRAVAS
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer (Section G)
NULL
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
jim vegel
6000 nathan lane north
zhongshan city
minneapolis, MN 55442
MDR Report Key15854472
Report Number3012307300-2022-27454
Device Sequence Number5076946
Product Code LJT
UDI-Device Identifier10610586023613
UDI-Public10610586023613
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K942024
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Distributor
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 05/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number21-4083-24
Device Catalogue Number21-4083-24
Device Lot Number4222399
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/10/2022
Supplement Date Received by Manufacturer03/17/2023
Initial Report FDA Received Date11/23/2022
Supplement Report FDA Received Date05/30/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/13/2021
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-